John William (John) Arbuthnot IV, a Senior Officer, Director and 10% Holder executive, acquired 25,000 Common Shares on a direct ownership basis at prices ranging from $1.530 and $1.540 through the public market on October 31st, 2018. This represents a $38,486 investment into the company's shares and an account share holdings change of 0.1%.
Delta 9 Cannabis is in the Pharmaceuticals Sub Industry Group under the Healthcare Sector.
Delta 9 Cannabis Inc , formerly SVT Capital Corp, is a Canada-based company engaged in Biotechnology & Medical Research. The principal activities of The Company are the production, storage and sale of medical marijuana.
No Comments